An Eye on Aquisition

Akrimax is actively exploring the acquisition of the following types of in-line, launch and development products:

  • Lipid lowering agents
  • Diabetes agents
  • Cardiovascular agents
  • Anti-obesity agents
  • Treatments for various metabolic disorders


Learn more about our commercialization and manufacturing capabilities

Have questions? Let’s talk.